Evidence map›Paper›PMID 24885389›Full record

ArticleBMC microbiology2014

Characterization of multi-drug tolerant persister cells in Streptococcus suis.

Jörg Willenborg, Daniela Willms, Ralph Bertram, Ralph Goethe, Peter Valentin-Weigand

Open access · goldAbstract read
In one paragraph

Article in BMC microbiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 48 citations in OpenAlex.

  1. Characterization of Antibiotic-Tolerant Persister Cells inAnimals : an open access journal from MDPI · 2026
    Article
  2. Article
  3. Cleavage ofbioRxiv : the preprint server for biology · 2025
    Article
  4. Review
  5. Review
  6. Ultrasound-Mediated Antibiotic Delivery to In Vivo Biofilm Infections: A Review.Chembiochem : a European journal of chemical biology · 2024
    Review
  7. Investigating group AmSphere · 2024
    Article
  8. Article
  9. Characterization ofMicroorganisms · 2024
    Article
  10. Article
  11. Antimicrobial polymer-loaded hydrogels for the topical treatment of multidrug-resistant wound biofilm infections.Journal of controlled release : official journal of the Controlled Release Society · 2023
    Article
  12. Genome Analysis ofPathogens (Basel, Switzerland) · 2023
    Article
  13. Article
  14. Are all antibiotic persisters created equal?Frontiers in cellular and infection microbiology · 2022
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Stress Physiology of Lactic Acid Bacteria.Microbiology and molecular biology reviews : MMBR · 2016
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Jörg WillenborgInstitute of Microbiology, University of Veterinary Medicine, Hannover, Germany. joerg.willenborg@tiho-hannover.de.
Daniela Willms
Ralph Bertram
Ralph Goethe
Peter Valentin-Weigand
University of Veterinary Medicine Hannover, Foundation · DEUniversity of Tübingen · DEUniversity of Veterinary Medicine Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPersister cells constitute a subpopulation of dormant cells within a microbial population which are genetically identical but phenotypically different to regular cells. Notably, persister cells show an elevated tolerance to antimicrobial agents. Thus, they are considered to represent a microbial 'bet-hedging' strategy and are of particular importance in pathogenic bacteria.

resultsWe studied the ability of the zoonotic pathogen Streptococcus (S.) suis to form multi-drug tolerant variants and identified persister cells dependent on the initial bacterial growth phase. We observed lower numbers of persisters in exponential phase cultures than in stationary growth phase populations. S. suis persister cells showed a high tolerance to a variety of antibiotics, and the phenotype was not inherited as tested with four passages of S. suis populations. Furthermore, we provide evidence that the persister phenotype is related to expression of genes involved in general metabolic pathways since we found higher numbers of persister cells in a mutant strain defective in the catabolic arginine deiminase system as compared to its parental wild type strain. Finally, we observed persister cell formation also in other S. suis strains and pathogenic streptococcal species.

conclusionsTaken together, this is the first study that reports multi-drug tolerant persister cells in the zoonotic pathogen S. suis.

Indexed as

Drug ToleranceAnti-Bacterial AgentsColony Count, MicrobialMicrobial Sensitivity TestsMicrobial ViabilityPhenotypeStreptococcus suisAnti-Bacterial Agents

Identifiers

PMID24885389
PMCPMC4040513
OpenAlexW1995093021

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.